Cambrex Industry Insights

  1. Leveraging New Technologies To Optimize And Accelerate R&D 7/23/2026

    Ingrid Ekman, Director of R&D at Cambrex Karlskoga, on why smoother tech transfer starts much earlier than most teams think — with systematic data and design of experiments that map a process's boundaries before it ever reaches commercial scale.

  2. Market Dynamics Related To The Development And Commercialization Of Peptides 7/23/2026

    Matt Bio, CSO of Cambrex and President of Snapdragon Chemistry, on the capacity bottleneck behind peptide shortages — and why moving from solid-phase to liquid-phase synthesis unlocks reactors already sitting idle around the world.

  3. Approaching Process Validation During Tech Transfer To Commercial Manufacturing 7/23/2026

    Matthew Schiesher, Head of R&D at Cambrex Charles City, on validating processes under the clock — and how running multiple sites in parallel shortens the path to launch when patients are waiting.

  4. Impactful Applications In Flow Chemistry And Radical Chemistry 7/23/2026

    Miles Blackburn, Associate Director of Chemistry at Snapdragon Chemistry, on why the biggest payoff of flow and radical chemistry is speed — processes that scale fast enough to get intermediates and APIs delivered on a clinical timeline.

  5. Trends And Technologies Shaping The Future Of API Manufacturing 7/23/2026

    Päivi Tolstoy, Manager of Process Development at Cambrex Karlskoga, on why sustainability is the trend to watch in API manufacturing — and why the real question is how few steps it takes to build a complex molecule.

  6. Liquid Phase Peptide Synthesis: Regulatory, Analytical, And QC Perspectives 10/3/2025

    Discover how Liquid Phase Peptide Synthesis (LPPS) uses traditional reactors to create more efficient and sustainable peptide manufacturing. Learn about key analytical and quality control considerations.

  7. Utilizing A Stepwise Approach For Nitrosamine Risk Mitigation 5/15/2025

    Insights and case studies demonstrate how a tailored, stepwise testing approach can effectively detect, quantify, and control nitrosamine impurities while maintaining cost efficiency.

  8. Removing The Headache: Outsourced Stability Storage And Testing Solutions 12/4/2024

    Should you manage certain operations internally or partner with a trusted external provider? Watch experts discuss the benefits of outsourcing stability, storage, and testing.

  9. Innovative Technology For Developing, Scaling Peptide-Based Therapeutics 11/18/2024

    Watch as experts walk through several technologies and case studies, focusing on liquid-phase peptide synthesis, crystallization, method development for impurity analysis, and more.

  10. Optimized Stability Storage 8/23/2024

    A healthcare manufacturer facing space constraints and regulatory pressures outsourced their stability storage needs to another company, resulting in reduced costs and focus on core competencies.